Simple test for throat cancer on the horizon?
NCT ID NCT06356272
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study from Mayo Clinic aims to find biological markers (biomarkers) in blood, tissue, and saliva that can signal the presence or absence of HPV-related oropharyngeal cancer. Researchers will follow 560 participants, including patients with and without the disease, to see if these markers can help with diagnosis and tracking outcomes. The goal is to develop a non-invasive way to detect cancer and monitor for recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood or saliva test to detect HPV-related throat cancer earlier and monitor for recurrence.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find a reliable biomarker, and any test developed would need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL STAGE III HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A gentler path after surgery for HPV throat cancer?
- Can less radiation be safer for throat cancer?
- Blood test may tailor throat cancer treatment, sparing patients from harsh side effects
- Can a Three-Pronged attack shrink Hard-to-Treat head and neck cancers?
- Can a simple swab predict who needs less radiation?
- New drug combo aims to shrink oral cancers before surgery